This topic contains a solution. Click here to go to the answer

Author Question: What are the ethical and practical considerations associated with inducing depression experimentally ... (Read 58 times)

Alainaaa8

  • Hero Member
  • *****
  • Posts: 576
What are the ethical and practical considerations associated with inducing depression experimentally in normal people?
 
  What will be an ideal response?

Question 2

Why would an ABA design not be appropriate for behavioral (as opposed to drug) treatment for depression?
 
  What will be an ideal response?



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jazzlynnnnn

  • Sr. Member
  • ****
  • Posts: 335
Answer to Question 1

Inducing depression could involve psychological harm. In addition, you have to have a way to relieve the depression before you can ethically let participants leave the lab. Fortunately, the effects researchers use are temporary and quite mild.
A practical problem involves how you would induce depression. One way was developed by Velten (1967), who asked participants to read increasing more depressed-sounding statements. It had the effect of inducing a mild version of depression, or a lowered mood.

Answer to Question 2

An ABA design presupposes that at the second baseline phase (i.e., the second A phase), the individual's behavior will return to the way it was before the treatment. In behavioral treatment for depression, if therapy is successful, the person will not return to his or her original depressed state. Thus, an ABA design will not be appropriate.




Alainaaa8

  • Member
  • Posts: 576
Reply 2 on: Jul 13, 2018
Gracias!


Dinolord

  • Member
  • Posts: 313
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Intradermal injections are somewhat difficult to correctly administer because the skin layers are so thin that it is easy to accidentally punch through to the deeper subcutaneous layer.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Congestive heart failure is a serious disorder that carries a reduced life expectancy. Heart failure is usually a chronic illness, and it may worsen with infection or other physical stressors.

For a complete list of videos, visit our video library